Authorization of Units. The board of directors of the Company (the “Board of Directors”) has authorized (i) the sale of up to 5.2 Units, each Unit consisting of (a) 208,333 shares of Common Stock and (b) a warrant to purchase 104,167 shares of Common Stock at an exercise price per share equal to $1.52, which warrant will be exercisable six months from the date of issuance for a period of five (5) years following the final Closing. From and after the applicable Closing, the Company shall issue and reserve for issuance the shares of its Common Stock issuable in such Closing; and (ii) the shares of Common Stock that may be issued upon full exercise of the Warrants (the “Warrant Shares”) issued at such Closing, plus such additional number of Warrant Shares as shall be required to be issued pursuant to the terms thereof.
Appears in 2 contracts
Samples: Unit Purchase Agreement, Unit Purchase Agreement (Medovex Corp.)
Authorization of Units. The board of directors of the Company (the “Board of Directors”) has authorized (i) the sale of up to 5.2 50 Units, each Unit consisting of (a) 208,333 shares of Common Stock 100,000 Preferred Shares and (b) a warrant to purchase 104,167 shares of Common Stock equal to 25% of the Conversion Shares at an exercise price per share equal to $1.520.25 per share, which warrant will be exercisable six months from the date of issuance immediately and for a period of five seven (57) years following the final Closingdate of issuance. From and after the applicable Closing, the Company shall issue and reserve for issuance the shares of its Common Stock issuable Conversion Shares in connection with such Closing; and (ii) the shares of Common Stock that may be issued upon full exercise of the Warrants (the “Warrant Shares”) issued at such Closing, plus such additional number of Warrant Shares as shall be required to be issued pursuant to the terms thereof.
Appears in 1 contract
Authorization of Units. The board of directors of the Company (the “Board of Directors”) has authorized (i) the sale of up to 5.2 20 Units, each Unit consisting of (a) 208,333 86,957 shares of Common Stock and (b) a warrant to purchase 104,167 43,378 shares of Common Stock at an exercise price per share equal to $1.521.30 per share, which warrant will be exercisable six months from the date of issuance for a period of five (5) years following the final Closing. From and after the applicable Closing, the Company shall issue and reserve for issuance the shares of its Common Stock issuable in such Closing; and (ii) the shares of Common Stock that may be issued upon full exercise of the Warrants (the “Warrant Shares”) issued at such Closing, plus such additional number of Warrant Shares as shall be required to be issued pursuant to the terms thereof.
Appears in 1 contract
Authorization of Units. The board of directors of the Company (the “Board of Directors”) has authorized (i) the sale of up to 5.2 45 Units, including the Over-Allotment; each Unit consisting of (a) 208,333 400,000 shares of Common Stock and (b) a warrant Warrant to purchase 104,167 200,000 shares of Common Stock at an exercise price of $0.375 per share equal to $1.52, which warrant will be exercisable six months from the date of issuance for a period of five (5) 3 years following from the final ClosingFinal Closing Date hereunder. From and after the applicable Closing, the Company shall issue and reserve reverse for issuance the (i) up to 18,000,000 shares of its Common Stock issuable in such ClosingStock; and (ii) the up to 9,000,000 shares of Common Stock that may be issued upon full exercise of the Warrants (the “Warrant Shares”) issued at such Closing, plus such additional number of Warrant Shares as shall be required to be issued pursuant to the terms thereofanti-dilution and adjustment provisions of the Warrants.
Appears in 1 contract
Samples: Unit Purchase Agreement (Protea Biosciences Group, Inc.)